Case Studies
VOC biomarkers – a novel approach to early detection, precision medicine and drug development, that’s already bearing fruit
Across the world, leading breath researchers are breaking ground establishing new clinical and pharmaceutical applications for VOC biomarkers, with much of the most exciting work underpinned by our Breath Biopsy and FAIMS technologies.
These case studies, many of which are from our academic and clinical partners, explore the untapped potential of VOCs across a wide range of disease areas.
There are a virtually unlimited range of applications across early detection and precision medicine for illnesses including respiratory diseases, cancer, gastrointestinal and cardiometabolic disease, as well as exposomics. Contact us to discuss how you can add breath research to your own research.
Distinguishing COPD from lung cancer in a large cohort study
Reviewing breath biomarkers for inflammatory respiratory diseases
Is breath acetone too ubiquitous to be a good biomarker of heart failure?
VOCs for bronchoconstriction in asthmatic children
Breath analysis for diagnosis of Pulmonary Arterial Hypertension
Could breath monitoring allow early intervention for COPD exacerbations?
Breath analysis for detecting cystic fibrosis and Pseudomonas exacerbations
Identifying Asthma and assessing control using Breath Biopsy
Breath Biopsy could diagnose IBD via VOCs produced in the gut
Learn about breath biomarkers and their applications. Download our free ebook.
